Skip to main content
Clinical Trials/NCT05374447
NCT05374447
Completed
Not Applicable

Evaluating the Diagnostic Yield and Specimen Quality With Endobronchial Ultrasound-Guided Intranodal Forceps Biopsies in Patients With Mediastinal and Hilar Lymphadenopathy: A Prospective Analysis

George Washington University1 site in 1 country55 target enrollmentJune 10, 2022

Overview

Phase
Not Applicable
Intervention
Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy
Conditions
Mediastinal Lymphadenopathy
Sponsor
George Washington University
Enrollment
55
Locations
1
Primary Endpoint
Diagnostic Yield
Status
Completed
Last Updated
18 days ago

Overview

Brief Summary

The investigators will compare endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) with intranodal forceps biopsy (EBUS-IFB) as it relates to the rate of diagnosis of suspected sarcoidosis.

Detailed Description

This is prospective, single center randomized comparative study to determine the diagnostic yield and specimen quality of endobronchial ultrasound guided intranodal forceps biopsy of patients with suspected sarcoidosis based solely on imaging. This will be a single group study and will compare transbronchial needle aspiration via 19 or 21-gauge needle with intranodal forceps biopsy. The study aims to answer a knowledge gap a as to whether the diagnostic yield and specimen quality of EBUS-TBNA with a 19G needle is less than those obtained by 1.9mm or greater intranodal forceps biopsy. The study proposed here will add to the field by further elucidating whether this procedure is beneficial for the diagnosis as it pertains to suspected sarcoidosis. The anticipated required enrollment is 55 patients to achieve an α of 0.05 and β of 0.2. This assumes an unassisted diagnostic yield of 62.5% with standard of care EBUS-TBNA as reported in Ray et al, and a diagnostic supplementation to 80% yield with intranodal forceps biopsies. References 1. Oki, M., Saka, H., \& Sako, C. (2004). Bronchoscopic miniforceps biopsy for mediastinal nodes. Journal of Bronchology \& Interventional Pulmonology, 11(3), 150-153. 2. Herth FJ, Morgan RK, Eberhardt R, Ernst A. Endobronchial ultrasound-guided miniforceps biopsy in the biopsy of subcarinal masses in patients with low likelihood of non-small cell lung cancer. Ann Thorac Surg. 2008 Jun; 85(6):1874-8. 3. Chrissian A, Misselhorn D, Chen A. Endobronchial-ultrasound guided miniforceps biopsy of mediastinal and hilar lesions. The Annals of Thoracic Surgery. 2011;92(1):284-288. 4. Franke KJ, Bruckner C, Szyrach M, Ruhle KH, Nilius G, Theegarten D. The contribution of endobronchial ultrasound-guided forceps biopsy in the diagnostic workup of unexplained mediastinal and hilar lymphadenopathy. Lung. 2012;190(2):227-232. 5. Herth FJF, Schuler H, Gompelmann D, et al. Endobronchial ultrasound-guided lymph node biopsy with transbronchial needle forceps: a pilot study. European Respiratory Journal. 2012;39(2):373-377. 6. Darwiche K, Freitag L, Nair A, et al. Evaluation of a novel endobronchial ultrasound-guided lymph node forceps in enlarged mediastinal lymph nodes. Respiration. 2013;86(3):229-236. 7. Ray AS, Li C, Murphy TE, et al. Improved diagnostic yield and specimen quality with endobronchial ultrasound-guided forceps biopsies: a retrospective analysis. The Annals of Thoracic Surgery. 2020;109(3):894-901

Registry
clinicaltrials.gov
Start Date
June 10, 2022
End Date
February 11, 2026
Last Updated
18 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Khalil Diab

MD - Associate Professor

George Washington University

Eligibility Criteria

Inclusion Criteria

  • Radiologic evidence of mediastinal and/or hilar lymphadenopathy
  • Attending radiologist or pulmonologist reports a possible diagnosis of sarcoidosis
  • Age 18 years or older

Exclusion Criteria

  • These are the characteristics that a participant must NOT have in order to be eligible to participate in the study.
  • Order Number Criteria
  • Severe pulmonary hypertension
  • Inability to undergo general anesthesia
  • Severe coagulopathy or bleeding diathesis
  • Previously diagnosed sarcoidosis
  • Patient presently taking clopidogrel
  • Patient deemed to be high risk for general anesthesia per anesthesiologist
  • Hemodynamic instability
  • Mediastinitis

Arms & Interventions

EBUS-TBNA

These will be the patient who undergo EBUS-TBNA only without EBUS-IFB

Intervention: Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy

EBUS-TBNA + EBUS-IFB

These will be the individuals who undergo EBUS-TBNA followed by EBUS-IFB in the same procedure

Intervention: Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy

Outcomes

Primary Outcomes

Diagnostic Yield

Time Frame: 1 year

Diagnostic yield of EBUS-TBNA + EBUS-IFB compared to EBUS-TBNA alone

Secondary Outcomes

  • Duration of Procedure(1 year)
  • Complications(1 year)

Study Sites (1)

Loading locations...

Similar Trials